NASDAQ CRON traded down $0.20 on Friday, hitting $5.70. 571,057 shares of the company were exchanged, compared to its average volume of 1,944,901. The company has a current ratio of 4.92, a quick ratio of 3.54 and a debt-to-equity ratio of 0.07. Cronos Group has a 1-year low of $1.00 and a 1-year high of $11.90.
About Cronos Group
Cronos Group Inc, formerly known as PharmaCan Capital Corp., is a principal investment firm. The firm seeks to invest in companies either licensed, or actively seeking a license, to produce medical marijuana pursuant to Canada’s Marihuana for Medical Purposes Regulations (?MMPR?). The firm typically invests in companies based in Canada.
Receive News & Ratings for Cronos Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cronos Group and related companies with MarketBeat.com's FREE daily email newsletter.